Novel group b streptococcus antigens
AssigneeID Biomedical Corporation of Quebec
InventorsBernard R. Brodeur, Clément Rioux, Martine Boyer, Isabelle Charlebois, Josée Hamel, Denis Martin
Life of this patent
Estimating the term…
Abstract
Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
Claims5
-28. (canceled)
An isolated antibody, or antigen-binding fragment thereof, that specifically binds to an isolated polypeptide consisting of the amino acid sequence set forth in SEQ ID NO:44.
(canceled)
Dependencies are inferred from the claim text.